Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00518453 | Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008 | PHASE2 | COMPLETED | 129 | — | — | Jul 1, 2007 | Aug 1, 2007 | Dec 1, 2016 | 1 | United Kingdom |
| Arm | Type | Description |
|---|---|---|
| Arm 1: Fluvirin | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| Surface antigen inactivated influenza vaccine | BIOLOGICAL | 1 dose of Fluvirin 2007/2008 Northern Hemisphere vaccine composition |
Inclusion Criteria: * Healthy Subjects eligible for enrollment into this study are male and female adult volunteers Exclusion Criteria: * Any serious disease